Table 2.
Toxicities experienced for 587 patients with esophageal or esophagogastric-junction cancer during concurrent chemoradiation therapy
| Toxicity | Patients, n (N = 587) | % |
|---|---|---|
| Weight loss | ||
| Grade 0 | 324 | 55.2 |
| Grade 1 | 196 | 33.4 |
| Grade 2 | 64 | 10.9 |
| Grade 3 | 3 | 0.5 |
| Fatigue | ||
| Grade 0 | 208 | 35.4 |
| Grade 1 | 168 | 28.6 |
| Grade 2 | 185 | 31.5 |
| Grade 3 | 26 | 4.4 |
| Dermatitis | ||
| Grade 0 | 324 | 55.2 |
| Grade 1 | 215 | 36.6 |
| Grade 2 | 39 | 6.6 |
| Grade 3 | 9 | 1.5 |
| Dysphagia | ||
| Grade 0 | 163 | 27.8 |
| Grade 1 | 146 | 24.9 |
| Grade 2 | 232 | 33.5 |
| Grade 3 | 45 | 7.7 |
| Grade 4 | 1 | 0.1 |
| Esophagitis | ||
| Grade 0 | 130 | 22.1 |
| Grade 1 | 98 | 16.7 |
| Grade 2 | 285 | 48.6 |
| Grade 3 | 72 | 12.3 |
| Grade 4 | 2 | 0.3 |
| Pneumonitis | ||
| Grade 0 | 530 | 90.3 |
| Grade 1 | 38 | 6.5 |
| Grade 2 | 11 | 1.9 |
| Grade 3 | 4 | 0.7 |
| Grade 5 | 4 | 0.7 |
| Nausea | ||
| Grade 0 | 272 | 46.3 |
| Grade 1 | 103 | 17.5 |
| Grade 2 | 176 | 30.0 |
| Grade 3 | 36 | 6.1 |
| Anorexia | ||
| Grade 0 | 388 | 66.1 |
| Grade 1 | 7482 | 14.0 |
| Grade 2 | 108 | 18.4 |
| Grade 3 | 9 | 1.5 |
| Hematologic | ||
| Grade 0 | 526 | 89.6 |
| Grade 1 | 24 | 4.1 |
| Grade 2 | 20 | 3.4 |
| Grade 3 | 16 | 2.7 |
| Grade 4 | 1 | 0.2 |